145 related articles for article (PubMed ID: 31075233)
1. Gene polymorphism and risk of idiopathic membranous nephropathy.
Liu D; Zhang J; Shi Y; Liu Z
Life Sci; 2019 Jul; 229():124-131. PubMed ID: 31075233
[TBL] [Abstract][Full Text] [Related]
2. Membranous nephropathy: A ten-year journey of discoveries.
Cai Q; Hendricks AR
Semin Diagn Pathol; 2020 May; 37(3):116-120. PubMed ID: 32061439
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy.
Kim S; Chin HJ; Na KY; Kim S; Oh J; Chung W; Noh JW; Lee YK; Cho JT; Lee EK; Chae DW;
Nephron Clin Pract; 2011; 117(3):c253-8. PubMed ID: 20805699
[TBL] [Abstract][Full Text] [Related]
4. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy.
Li P; Wei RB; Tang L; Wu J; Zhang XG; Chen XM
Clin Nephrol; 2012 Dec; 78(6):456-64. PubMed ID: 23164414
[TBL] [Abstract][Full Text] [Related]
6. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy.
Zhu X; Kong D; Zhang L; Sun Y; Na S; Han C; Jin X
Hum Pathol; 2013 Dec; 44(12):2806-13. PubMed ID: 24157068
[TBL] [Abstract][Full Text] [Related]
7. Immunology of membranous nephropathy.
Akiyama S; Imai E; Maruyama S
F1000Res; 2019; 8():. PubMed ID: 31168358
[TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of the development and course of membranous nephropathy.
Kamyshova ES; Bobkova IN; Gorelova IA; Каkhsurueva PA; Filatova EE
Ter Arkh; 2018 Jun; 90(6):105-111. PubMed ID: 30701913
[TBL] [Abstract][Full Text] [Related]
9. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.
Chen CH; Shu KH; Wen MC; Chen KJ; Cheng CH; Lian JD; Wu MJ; Yu TM; Tsai FJ
Nephrol Dial Transplant; 2008 Oct; 23(10):3166-73. PubMed ID: 18495745
[TBL] [Abstract][Full Text] [Related]
10. Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods.
VanBeek C; Haas M
Clin Nephrol; 2015 Jul; 84(1):1-9. PubMed ID: 25997506
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of membranous nephropathy: evolution and revolution.
Glassock RJ
Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552
[TBL] [Abstract][Full Text] [Related]
13. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H
Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
[TBL] [Abstract][Full Text] [Related]
15. Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy.
Dong HR; Wang YY; Cheng XH; Wang GQ; Sun LJ; Cheng H; Chen YP
PLoS One; 2016; 11(5):e0156263. PubMed ID: 27223897
[TBL] [Abstract][Full Text] [Related]
16. Two brothers with idiopathic membranous nephropathy and familial sensorineural deafness.
Meroni M; Volpi A; Usberti M; Battini G; Tarelli LT; Giordano F; Sessa A
Am J Kidney Dis; 1990 Mar; 15(3):269-72. PubMed ID: 2305767
[TBL] [Abstract][Full Text] [Related]
17. Biomarker prediction for membranous nephropathy prognosis by microarray analysis.
Zhou G; Xin G; Zhang W; Zhang X
Nephrology (Carlton); 2019 May; 24(5):526-533. PubMed ID: 30084529
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases.
Hu R; Xing G; Wu H; Zhang Z
Diagn Pathol; 2016 Sep; 11(1):86. PubMed ID: 27624606
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
20. Primary membranous nephropathy: comprehensive review and historical perspective.
Keri KC; Blumenthal S; Kulkarni V; Beck L; Chongkrairatanakul T
Postgrad Med J; 2019 Jan; 95(1119):23-31. PubMed ID: 30683678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
